Tolerability of the concomitant use of tacrolimus and methotrexate in the treatment of rheumatoid arthritis.

被引：0
|
作者：
Szczepanski, L
Szerla, J
Venalis, A
Breitbart, A
Fiehn, C
Zeidler, H
机构：
[1] Univ Lublin, Sch Med, Lublin, Poland
[2] Krakowski Szpital Reumatol & Rehabil, Krakow, Poland
[3] Univ Vilnus, Dept Rheumatol, Vilnus, Lithuania
[4] Univ Heidelberg, Med Klin & Poliklin 5, Heidelberg, Germany
[5] Med Hsch Hannover, Abt Rheumatol, Hannover, Germany
来源：
ARTHRITIS AND RHEUMATISM | 2003年 / 48卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
203
引用
收藏
页码：S120 / S121
页数：2
相关论文
共 50 条
  • [21] Disparities in the use of biologic therapies for the treatment of rheumatoid arthritis.
    Berrios-Rivera, Javier P.
    Johnson, Michael L.
    Huston, David P.
    Suarez-Almazor, Maria E.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S347 - S347
  • [22] Effect and Safety of Concomitant Methotrexate and Tacrolimus on Clinical Response of Abatacept in Rheumatoid Arthritis Patients with Prior Use of Biological Dmards.
    Takahashi, Nobunori
    Kojima, Toshihisa
    Hirano, Yuji
    Kanayama, Yasuhide
    Funahashi, Koji
    Ishiguro, Naoki
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S222 - S223
  • [23] Glucocorticoid use in rheumatoid arthritis.
    Saag K.G.
    Current Rheumatology Reports, 2002, 4 (3) : 218 - 225
  • [24] Drug use in rheumatoid arthritis.
    MacLean, CH
    Knight, KK
    Shekelle, PG
    Paulus, HE
    Brook, RH
    ARTHRITIS AND RHEUMATISM, 1996, 39 (06): : R5 - R5
  • [25] Treatment of rheumatoid arthritis in the USA: premature use of tumor necrosis factor inhibition and underutilization of concomitant methotrexate
    O'Dell, James R.
    Cohen, Stanley B.
    Thorne, J. Carter
    Kremer, Joel
    OPEN ACCESS RHEUMATOLOGY-RESEARCH AND REVIEWS, 2018, 10 : 97 - 101
  • [26] Efficacy of adjunct tacrolimus treatment in patients with rheumatoid arthritis with inadequate responses to methotrexate
    Kitahama, Mariko
    Nakajima, Ayako
    Inoue, Eisuke
    Taniguchi, Atsuo
    Momohara, Shigeki
    Yamanaka, Hisashi
    MODERN RHEUMATOLOGY, 2013, 23 (04) : 788 - 793
  • [27] A comparison of the renal effects of leflunomide, methotrexate, and sulfasalazine during treatment of rheumatoid arthritis.
    Schiff, M
    Whelton, A
    Strand, V
    ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S351 - S351
  • [28] Risk of opportunistic infections following low dose methotrexate treatment for rheumatoid arthritis.
    McCann, TJ
    Koepsell, TD
    Schwartz, SM
    Nelson, JL
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2001, 153 (11) : S253 - S253
  • [29] Combination treatment with infliximab and methotrexate or leflunomide in active rheumatoid arthritis. Safety and efficacy
    Athanassiou, P
    Kostoglou-Athanassiou, I
    Koutsogeorgopoulou, L
    Galanaki, C
    Kordalis, A
    Konstantopoulou, R
    Sarlanis, T
    Vezyroglou, G
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 464 - 464
  • [30] Persistence On Biologics Is Associated With Concomitant Methotrexate Use Among Rheumatoid Arthritis Patient
    Zhang, Jie
    Xie, Fenglong
    Delzell, Elizabeth S.
    Yun, Huifeng
    Lewis, James
    Haynes, Kevin
    Chen, Lang
    Curtis, Jeffrey R.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S990 - S991
12345